中文| English
Home
About
Company Introduction
Vision and Mission
Subsidiary enterprises
Contact Us
Ability
Core business
Brand Story
Core Advantages
Blog
Company News
Investor Relations
Sustainable
Our Commitment
Our goal
Our actions
Social honor
Social Responsibility Report
Cultural Heritage
Tibetan medical knowledge
File Download
Technological innovation
Evidence-based medicine
Care for Health
Consumer Q&A
Tibetan medical consultation
Human development
Why choose us?
Industry Standards
Training and Development
Employee Highlights
The Top 100 Chinese Traditional Medicine Enterprises List Has Been Released—Qizheng Tibetan Medicine Appears on the List Again!
2022-07-15
Belarusian Ambassador to China Yuri Sienko Visits Gansu’s Tibetan Medicine and Culture.
2022-07-08
With “excellent” disclosure quality, Qizheng Tibetan Medicine has received an “A” rating in the Shenzhen Stock Exchange’s disclosure assessment for seven consecutive years.
2022-07-05
Gansu Province donates a batch of “Gansu Formulas,” Tibetan medicine prescriptions, to Belarus.
2022-07-01
Qizheng Tibetan Medicine’s net profit grew by 77.21% in 2021, and it plans to distribute a cash dividend of 5.9 yuan for every 10 shares held.
2022-04-29
Qizheng Tibetan Medicine has been awarded the “Best New Media Operations Award for Investor Relations of Chinese Listed Companies.”
2022-04-22
Qizheng Tibetan Medicine once again receives two prestigious awards from CSR CHINA.
2021-12-06
Qizheng Tibetan Medicine Honored as a “2021 National Demonstration Enterprise for Technological Innovation”
2021-12-02
Qizheng Tibetan Medicine Selected as Part of the First Batch of China’s OTC Brand Cluster
2021-10-21
Qizheng Tibetan Medicine has been named industry champion and ranked among the Top 10 brands with the fastest value growth on the “Hurun Billion-Dollar Potential Brand List.”
2021-10-14
Further Boost for Medical Insurance Access Support—New Opportunities for Ethnic Medicines
2021-09-28
Qizheng Tibetan Medicine Wins the “China Listed Companies Social Responsibility Award” Again
Deepening its presence in the pain management market, Dingdang Kuaiyao and Qizheng Tibetan Medicine sign a strategic agreement for 2022.
2021-09-23
In the first half of the year, Qizheng Tibetan Medicine achieved a revenue growth of approximately 28% year-on-year, and its net profit increased by more than 300% year-on-year.
2021-08-26
Qizheng Tibetan Medicine’s net profit for the first half of the year is expected to increase by 329% to 355% year-on-year.
2021-07-14